Does MICAFUNGIN Cause Product use in unapproved indication? 192 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 192 reports of Product use in unapproved indication have been filed in association with MICAFUNGIN (Micafungin). This represents 6.2% of all adverse event reports for MICAFUNGIN.
192
Reports of Product use in unapproved indication with MICAFUNGIN
6.2%
of all MICAFUNGIN reports
48
Deaths
124
Hospitalizations
How Dangerous Is Product use in unapproved indication From MICAFUNGIN?
Of the 192 reports, 48 (25.0%) resulted in death, 124 (64.6%) required hospitalization, and 11 (5.7%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MICAFUNGIN. However, 192 reports have been filed with the FAERS database.
What Other Side Effects Does MICAFUNGIN Cause?
Drug ineffective (608)
Off label use (537)
Death (138)
Fungal infection (132)
Multiple organ dysfunction syndrome (129)
Candida infection (127)
Pyrexia (112)
Product use issue (105)
Diarrhoea (104)
Acute kidney injury (98)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which MICAFUNGIN Alternatives Have Lower Product use in unapproved indication Risk?
MICAFUNGIN vs MICARDIS
MICAFUNGIN vs MICONAZOLE
MICAFUNGIN vs MIDAZOLAM
MICAFUNGIN vs MIDAZOLAM\MIDAZOLAM
MICAFUNGIN vs MIDODRINE